WINDTREE THERAPEUTICS INC /DE/
DelistedCIK 946486fmd_0TTTVBQR070R6YYV0JZYMK5AWYManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2010 to Sep 30, 2025, 62 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 2 | 1 | 2 | 0 | – | – | – | – | – |
| Cost of revenue | 1 | – | – | – | – | – | – | – | – | – |
| Gross profit | 0 | – | – | – | – | – | – | – | – | – |
| Realized investment gains (losses) | – | – | – | – | 0 | – | – | – | – | – |
| Research and development | 29 | 32 | 17 | 11 | 13 | 15 | 18 | 11 | 8 | 16 |
| Selling, general and administrative | 11 | 8 | 7 | 7 | 12 | 15 | 14 | 11 | 9 | 9 |
| Total operating expenses | 41 | 40 | 24 | 18 | 25 | 30 | 77 | 41 | 21 | 26 |
| Operating income | (40) | (38) | (23) | (16) | (25) | (30) | (77) | (41) | (21) | (26) |
| Interest expense | 5 | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (16) | (2) | 4 | (4) | (3) | (2) | (0) | 1 | 0 | 24 |
| Income before taxes | – | – | – | – | – | (33) | (78) | (41) | (20) | (2) |
| Income tax expense | 0 | – | – | – | – | 0 | (10) | (1) | 0 | (0) |
| Net income from continuing operations | – | – | – | – | – | (33) | (68) | (39) | (20) | (2) |
| Net income | (55) | (39) | (18) | (21) | (27) | (33) | (68) | (39) | (20) | (2) |
| Net income to common shareholders | (56) | (39) | (25) | (35) | (27) | – | – | – | (20) | (5) |